Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone.
about
Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsAntiparasitic agent atovaquoneAtovaquone-proguanil for prophylaxis and treatment of malaria.Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian populationPopulation pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory CoastPrediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administrationDosing rationale for fixed-dose combinations in children: shooting from the hip?Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum.
P2860
Q30847884-CC58B4AA-EF42-49A2-B7F7-6D8681E082F5Q34058304-3DDC9182-C478-495B-928C-91ED46F1AA6AQ34107885-BB498BFF-F7F2-46DD-ACAA-95FF33398113Q35201039-827E0AD8-DA20-4467-BED9-1B78A4779306Q35802629-A9345463-0CF2-48DE-A767-7D1AE9834EEEQ35802755-2DFD93C0-4A35-454C-A98E-178B9286C5A9Q36249089-AADAD43D-81E1-4298-8B49-381D99630602Q38627882-6D8CA351-3322-47AA-A3E4-C00A1C272C35Q40571679-CDE5C839-513B-4DA7-B34A-02DBB9FDFA41Q42565032-62D11107-44FE-41B1-9BC4-E2AB251BB49EQ44677507-FF706FB6-9A0E-4321-A350-132AB2FBDBEEQ48036778-EC04341B-23C1-41F3-A61F-E0A9B7A90D18
P2860
Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Population pharmacokinetics of ...... bined therapy with atovaquone.
@en
Population pharmacokinetics of ...... bined therapy with atovaquone.
@nl
type
label
Population pharmacokinetics of ...... bined therapy with atovaquone.
@en
Population pharmacokinetics of ...... bined therapy with atovaquone.
@nl
prefLabel
Population pharmacokinetics of ...... bined therapy with atovaquone.
@en
Population pharmacokinetics of ...... bined therapy with atovaquone.
@nl
P2093
P2860
P1476
Population pharmacokinetics of ...... bined therapy with atovaquone.
@en
P2093
Canfield CJ
Hutchinson DB
P2860
P304
P356
10.1111/J.1365-2125.1996.TB00114.X
P407
P577
1996-11-01T00:00:00Z